What is PHAT's dilution risk score?

PHAT has a latest available DilutionScore record of 46/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PHAT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PHAT?

DilutionWatch tracks 25 SEC filing types for PHAT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PHAT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PHAT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PHAT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PHAT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PHAT Dilution Risk Score: 46/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

65

📊 Float Risk

30

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

💰 Capital Raise model 15%

• Under 12 months cash (10mo)

🔔 Track PHAT — Get forecast alerts →

Market Data

Market Cap$764.86M

Shares Outstanding80.90M

Float60.39M

Cash$182.48M

Debt$164.59M

Short InterestN/A

Institutional Holdings

179 institutional holders · 75.42M shares

#1 Frazier Life Sciences Management, L.P. 12.47M shares

#2 Medicxi Ventures Management (Jersey) Ltd 7.46M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 5.17M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.33M

Days to Cover8.7

% of Float22.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2019-12-31

4 INSIDER TRANSACTION 2026-03-11

4 INSIDER TRANSACTION 2026-03-03

4 INSIDER TRANSACTION 2026-02-12

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PHAT Dilution Snapshot

Phathom Pharmaceuticals, Inc. (PHAT) has a DilutionScore of 46/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for PHAT: 4 on 2026-03-11; 4 on 2026-03-03; 4 on 2026-02-12.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.